ArticleCancers2024

Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma.

Gabriele Roccuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.